Isatuximab in type I cryoglobulinaemia: A prospective pilot study research hub

Isatuximab in type I cryoglobulinemia: A prospective pilot study / ICE STUDY

This study is looking at a new medicine called Isatuximab for people with a rare condition called type I cryoglobulinemia. It aims to see how well the medicine can reduce symptoms of blood vessel inflammation (vasculitis) and if it is safe to use. This is an early-stage study.